Concepedia

Miika Ahdesmäki

MA

20

Publications

2.9K

Citations

17

H-Index

2005

Active since

Affiliations

AstraZeneca (United Kingdom)(Current)

AstraZeneca (United States)

AstraZeneca (Singapore)

Institute for Systems Biology

Miika Ahdesmäki is an author at AstraZeneca (United Kingdom) specializing in medicine, cancer research, and tumor heterogeneity.

ORCID

Top concepts

Publications per year

2005–2022

20

Publications

20

VarDict: a novel and versatile variant caller for next-generation sequencing in cancer research

Zhongwu Lai, Aleksandra Markovets, Miika Ahdesmäki et al. · Nucleic Acids Research · 2016 · 1K citations · Full text

, , +20

Rational Selection of Syngeneic Preclinical Tumor Models for Immunotherapeutic Drug Discovery

Suzanne I.S. Mosely, John E. Prime, Richard C.A. Sainson et al. · Cancer Immunology Research · 2016 · 407 citations

, , +21

Acquired Resistance to the Mutant-Selective EGFR Inhibitor AZD9291 Is Associated with Increased Dependence on RAS Signaling in Preclinical Models

Catherine A. Eberlein, Daniel Stetson, Aleksandra Markovets et al. · Cancer Research · 2015 · 293 citations · Full text

Development and Independent Validation of a Prognostic Assay for Stage II Colon Cancer Using Formalin-Fixed Paraffin-Embedded Tissue

Richard D. Kennedy, Max Bylesjö, Peter Kerr et al. · Journal of Clinical Oncology · 2011 · 187 citations

AZD5153: A Novel Bivalent BET Bromodomain Inhibitor Highly Active against Hematologic Malignancies

Garrett W. Rhyasen, Maureen M. Hattersley, Yi Yao et al. · Molecular Cancer Therapeutics · 2016 · 147 citations · Full text

, , +17

Rows per page

1–5 of 20